Evommune (EVMN) CFO boosts stake with 1,000-share buy, repays $10,160 profit
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Evommune, Inc. Chief Financial Officer Kyle Carver purchased 1,000 shares of common stock in an open-market transaction at $13.26 per share, bringing his direct holdings to 60,335 shares. A prior sale of 1,000 shares at $23.42 on May 28, 2026 triggered Section 16(b) short-swing profit rules, and he agreed to pay $10,160 of profit to Evommune.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,000 shares ($13,260)
Net Buy
1 txn
Insider
Carver Kyle
Role
Chief Financial Officer
Bought
1,000 shs ($13K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 1,000 | $13.26 | $13K |
Holdings After Transaction:
Common Stock — 60,335 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Shares purchased: 1,000 shares
Purchase price: $13.26 per share
Shares held after transaction: 60,335 shares
+2 more
5 metrics
Shares purchased
1,000 shares
Open-market purchase of common stock on July 8, 2026
Purchase price
$13.26 per share
Price paid for 1,000 Evommune common shares
Shares held after transaction
60,335 shares
Direct holdings of CFO Kyle Carver following the purchase
Prior sale price
$23.42 per share
Price for 1,000 shares sold on May 28, 2026, matched under Section 16(b)
Short-swing profit remitted
$10,160
Amount the reporting person agreed to pay to Evommune
Key Terms
Section 16(b), short-swing transaction, open-market purchase
3 terms
Section 16(b) regulatory
"matchable under Section 16(b) of the Securities Exchange Act of 1934"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
short-swing transaction regulatory
"profit realized in connection with the short-swing transaction"
open-market purchase financial
"transaction_action: open-market purchase"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
FAQ
What insider transaction did Evommune (EVMN) report for CFO Kyle Carver?
Evommune reported that CFO Kyle Carver bought 1,000 shares of common stock in the open market at $13.26 per share, increasing his direct ownership to 60,335 shares.
What earlier Evommune (EVMN) stock sale was matched under Section 16(b)?
The filing notes a prior sale by CFO Kyle Carver of 1,000 shares of Evommune common stock at $23.42 per share on May 28, 2026, which was matchable under Section 16(b).
How much short-swing profit will be paid back to Evommune (EVMN) under Section 16(b)?
The reporting person agreed to pay Evommune $10,160, representing the full profit realized from the Section 16(b) short-swing transaction involving the matched purchase and sale of 1,000 shares.